Kahn Swick & Foti Investigates Adequacy of Arcellx Sale to Gilead Sciences

viernes, 13 de marzo de 2026, 4:07 pm ET1 min de lectura
ACLX--
GILD--

Kahn Swick & Foti, LLC is investigating the proposed sale of Arcellx, Inc. to Gilead Sciences, Inc. The law firm is seeking to determine whether the consideration and process are adequate, or if the consideration undervalues the company. If you believe the transaction undervalues Arcellx, you may contact KSF at 855-768-1857 or visit their website to learn more.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios